📊 SFES Key Takeaways
Is Safeguard Scientifics Inc. (SFES) a Good Investment?
SFES is a financially distressed investment company with persistent operating losses (28.2% net margin), negative cash flow generation, and critically elevated leverage where long-term debt ($68.6M) exceeds total assets ($22.8M). Despite minor YoY loss improvements, the structural balance sheet imbalance and inability to generate positive operating cash flow pose severe viability risks.
Why Buy Safeguard Scientifics Inc. Stock? SFES Key Strengths
- Strong current liquidity ratio (4.84x) provides near-term operational runway
- Net loss improved 31.1% YoY suggesting potential stabilization trajectory
- Positive stockholders' equity of $20.0M maintains some residual equity cushion
SFES Stock Risks: Safeguard Scientifics Inc. Investment Risks
- Long-term debt ($68.6M) exceeds total assets ($22.8M) indicating severe balance sheet insolvency risk
- Negative operating cash flow (-$3.3M) demonstrates unsustainable cash burn and operational distress
- Persistent unprofitability with -28.2% net margin and negative ROE (-49.2%) destroying shareholder value
Key Metrics to Watch
- Operating cash flow trajectory - must turn positive for sustainability
- Debt reduction progress - critical to improve debt-to-asset ratio
- Underlying portfolio investment performance - primary revenue driver for investment company
Safeguard Scientifics Inc. (SFES) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 4.84x current ratio provides a solid financial cushion.
SFES Profit Margin, ROE & Profitability Analysis
SFES vs Market Sector: How Safeguard Scientifics Inc. Compares
How Safeguard Scientifics Inc. compares to Market sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Safeguard Scientifics Inc. Stock Overvalued? SFES Valuation Analysis 2026
Based on fundamental analysis, Safeguard Scientifics Inc. shows some fundamental concerns relative to the Market sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Safeguard Scientifics Inc. Balance Sheet: SFES Debt, Cash & Liquidity
SFES Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Safeguard Scientifics Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-0.40 indicates the company is currently unprofitable.
SFES Revenue Growth, EPS Growth & YoY Performance
Safeguard Scientifics Inc. Dividends, Buybacks & Capital Allocation
SFES SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Safeguard Scientifics Inc. (CIK: 0000086115)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SFES
What is the AI rating for SFES?
Safeguard Scientifics Inc. (SFES) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SFES's key strengths?
Claude: Strong current liquidity ratio (4.84x) provides near-term operational runway. Net loss improved 31.1% YoY suggesting potential stabilization trajectory.
What are the risks of investing in SFES?
Claude: Long-term debt ($68.6M) exceeds total assets ($22.8M) indicating severe balance sheet insolvency risk. Negative operating cash flow (-$3.3M) demonstrates unsustainable cash burn and operational distress.
What is SFES's revenue and growth?
Safeguard Scientifics Inc. reported revenue of $34.8M.
Does SFES pay dividends?
Safeguard Scientifics Inc. pays dividends, with $5.8M distributed to shareholders in the trailing twelve months.
Where can I find SFES SEC filings?
Official SEC filings for Safeguard Scientifics Inc. (CIK: 0000086115) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SFES's EPS?
Safeguard Scientifics Inc. has a diluted EPS of $-0.61.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is SFES a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Safeguard Scientifics Inc. has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is SFES stock overvalued or undervalued?
Valuation metrics for SFES: ROE of -49.2% (sector avg: 15%), net margin of -28.2% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy SFES stock in 2026?
Our dual AI analysis gives Safeguard Scientifics Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SFES's free cash flow?
Safeguard Scientifics Inc.'s operating cash flow is $-3.3M, with capital expenditures of $0.0. FCF margin is -9.5%.
How does SFES compare to other Market stocks?
Vs Default sector averages: Net margin -28.2% (avg: 12%), ROE -49.2% (avg: 15%), current ratio 4.84 (avg: 1.8).
Is Safeguard Scientifics Inc. carrying too much debt?
SFES has a debt-to-equity ratio of 3.43x, which is above the Market sector average of 0.7x. However, the current ratio of 4.84 suggests adequate short-term liquidity.